- Citations, last 5 years
- 0
- Works, last 5 years
- 1
- h-index
- 34
- Scientists listed
- 0
- Grants since 2016
- 6
Grants received
2023–2025 · research · R44
Validation and Early Commercialization of the ENVISAGE Assay, a Prognostic Test for Barrett's Esophagus
Sarah Laun · Capsugel (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Validation and Early Commercialization of the ENVISAGE Assay, a Prognostic Test for Barrett's Esophagus
Sarah Laun · Capsugel (United States) · funded by National Institutes of Health
2021–2026 · research · R42
An accurate, affordable, and transferable assay for minimally invasive detection of esophageal squamous cell carcinoma (ESCC) in Africa and the United States
Sarah Laun · Capsugel (United States) · funded by National Institutes of Health
2021–2023 · research · R41
Diagnosis of Esophageal Squamous Cell Carcinoma in Low-Income Countries
Daniel Gregory Lunz · Capsugel (United States) · funded by National Institutes of Health
2020–2021 · research · R41
A Novel Strategy for Diagnosis of Esophageal Adenocarcinoma.
John M Abraham · Capsugel (United States) · funded by National Institutes of Health
2020–2022 · research · R41
A Novel Strategy for Diagnosis of Esophageal Adenocarcinoma.
Daniel Gregory Lunz · Capsugel (United States) · funded by National Institutes of Health